Discover
AVDL
Avadel Pharmaceuticals PLC
21.64
2 x 15.60
2 x 27.73
bid
ask
+
0.00
0.00%
2 @ 04:00 PM
21.65 +0.01 (0.05%)
| Ytd | 0.42% | |
| 1y | 140.71% |
21.63
day range
21.76
52 week range
| Open | 21.65 | Prev Close | 21.64 | Low | 21.63 | High | 21.76 | Mkt Cap | N/A |
| Vol | 35.02M | Avg Vol | 0.00 | EPS | N/A | P/E | N/A | Forward P/E | 27.74 |
| Beta | 1.63 | Short Ratio | 1.60 | Inst. Own | 86.80% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | N/A | 50-d Avg | N/A | 200-d Avg | N/A | 1yr Est | 20.71 |
| Income Statement | |||
| Total Revenue | 77.47M | ||
| Revenues (USD) | 77.47M | ||
| Cost of Revenue | -4.12M | ||
| Gross Profit | 81.58M | ||
| Operating Expenses | 79.65M | ||
| Research and Development Expense | 27.01M | ||
| Selling, General and Administrative Expense | 52.64M | ||
| Operating Income | 1.94M | ||
| Interest Expense | 2.42M | ||
| Income Tax Expense | 34.00K | ||
| Net Income | 20.00K | ||
| Net Income Common Stock | 20.00K | ||
| Net Income Common Stock (USD) | 20.00K | ||
| Consolidated Income | 20.00K | ||
| Earning Before Interest & Taxes (EBIT) | 2.47M | ||
| Earning Before Interest & Taxes (USD) | 2.47M | ||
| Weighted Average Shares | 97.10M | ||
| Weighted Average Shares Diluted | 101.28M | ||
| Balance Sheet | |||
| Cash and Equivalents | 79.81M | ||
| Cash and Equivalents (USD) | 79.81M | ||
| Investments | 11.76M | ||
| Investments Current | 11.76M | ||
| Trade and Non-Trade Receivables | 42.44M | ||
| Current Assets | 172.23M | ||
| Property, Plant & Equipment Net | 3.01M | ||
| Total Assets | 199.45M | ||
| Debt Current | 740.00K | ||
| Total Debt | 37.38M | ||
| Current Liabilities | 62.49M | ||
| Debt Non-Current | 36.64M | ||
| Total Liabilities | 101.22M | ||
| Accumulated Retained Earnings (Deficit) | -789.56M | ||
| Accumulated Other Comprehensive Income | -23.58M | ||
| Shareholders Equity | 98.23M | ||
| Shareholders Equity (USD) | 98.23M | ||
| Assets Non-Current | 27.22M | ||
| Total Debt (USD) | 37.38M | ||
| Goodwill and Intangible Assets | 16.84M | ||
| Inventory | 23.91M | ||
| Liabilities Non-Current | 38.74M | ||
| Trade and Non-Trade Payables | 12.58M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 1.12M | ||
| Net Cash Flow from Financing | 2.51M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 16.41M | ||
| Capital Expenditure | -9.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | -15.00M | ||
| Issuance (Purchase) of Equity Shares | 2.51M | ||
| Net Cash Flow from Investing | -8.43M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 6.58M | ||
| Net Cash Flow from Operations | 22.21M | ||
| Effect of Exchange Rate Changes on Cash | 132.00K | ||
| Share Based Compensation | 4.92M | ||